Sign in
4

Changes in Ownership

Adaptive Biotechnologies Corp Filed Acc 0001209191-21-006311

Chief Medical Officer sold 40,000 shares at an average $58.95 ($2,358,117)

  • Chief Medical Officer acquired 40,000 shares (option exercise)

From the SEC's structured data for this filing

Trades in this filing

BALDO LANCE · Chief Medical Officer

Table I: Non-derivative

4 lines
Date Transaction Shares Price Value Owned after D/I
2021-01-27 Exercise or conversion : show line 1 in the form +40,000 $7.80 $312,000 40,000 D
2021-01-27 Sale : show line 2 in the form −17,499 $58.22 $1,018,792 22,501 D
2021-01-27 Sale : show line 3 in the form −14,233 $59.24 $843,163 8,268 D
2021-01-27 Sale : show line 4 in the form −8,268 $60.01 $496,163 0 D
Open-market sales · 40,000 sh · avg $58.95 · $2,358,117

Table II: Derivative

1 line
Date Transaction Shares Owned after D/I
2021-01-27 Exercise or conversion : show line 5 in the form Stock Option (Right to Buy) −40,000 341,250 D
Loading xslF345X03/doc4.xml…